China Drugmakers Axe IPO Plans as They Face Scrutiny in Antigraft Drive ...Middle East

Healthcare companies in China are shelving their initial public offering plans as its stock exchanges have stepped up scrutiny of the pharmaceutical industry's business practices. Reuters Health Information

Hence then, the article about china drugmakers axe ipo plans as they face scrutiny in antigraft drive was published today ( Monday 14/08/2023 - 04:48 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( China Drugmakers Axe IPO Plans as They Face Scrutiny in Antigraft Drive )

Also on site :

• Beyoncé, Pam Grier Are This '90s Actress and Soap Star's 'Role Models'
• Body of second US soldier missing in Morocco recovered
• American multimillionaire found dead in London mansion after argument with wife over airline ticket, inquest told